TCEAL7 and glioblastoma: One recent study suggested that miR-301a in exosomes secreted by hypoxic glioma cells activated the Wnt/β-catenin signal pathway by targeting TCEAL7 and improved radiotherapy resistance and that TCEAL7 was a confirmed GBM suppressor gene [75].